Vanguard Group Inc Roivant Sciences Ltd. Put Options Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ROIV
# of Institutions
319Shares Held
504MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$761 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$718 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$553 Million1.91% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$409 Million0.01% of portfolio
-
Morgan Stanley New York, NY34.6MShares$400 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.15B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...